SENEXON-S by NCS HealthCare of KY, Inc dba Vangard Labs
Medically reviewed on August 23, 2017
Dosage form: tablet, coated
Ingredients: SENNOSIDES A AND B 8.6mg, DOCUSATE SODIUM 50mg
Labeler: NCS HealthCare of KY, Inc dba Vangard Labs
NDC Code: 0615-7773
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Docusate sodium 50 mg
Sennosides 8.6 mg
• relieves occasional constipation
• generally produces bowel movement in 6 - 12 hours
Do not use • if you are taking mineral oil • for longer than one week • when abdominal pain, nausea or vomiting are present
Ask a doctor before use if you have noticed a sudden change in bowel habits that lasts over two weeks
Ask a doctor or pharmacist before use if you are taking any other drug. Take this product two or more hours before or after other drugs. Laxatives may affect how other drugs work.
Stop use and ask a doctor if • you have rectal bleeding • you fail to have a bowel movement after use of this product.
These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
• take preferably at bedtime or as directed by a doctor
• if you do not have a comforable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage)
|age||starting dosage||maximum dosage|
|adults and children 12 years and older||2 tablets once daily||4 tablets twice daily|
|children 5 to under 12 years||1 tablet once daily||2 tablets twice daily|
|children 2 to under 6 years||1/2 tablet once daily||1 tablet twice daily|
|children under 2 years||ask a doctor||ask a doctor|
• each tablet contains: calcium 20 mg, sodium 6 mg (LOW SODIUM)
• store at 20º - 25ºC (68º - 77ºF)
carnauba wax, colloidal silicon dioxide, croscarmellose sodium, D&C yellow #10 aluminum lake, dibasic calcium phosphate dihydrate, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, titanium dioxide
Dispense contents with a child-resistant closure in a tight, light-resistant container as defined in the USP.
Distributed by: Rugby Laboratories
31778 Enterprise Drive, Livonia, MI 48150
R-14 Rev. 03/13
docusate sodium-sennosides tablet tablet, coated
|Labeler - NCS HealthCare of KY, Inc dba Vangard Labs (050052943)|
|NCS HealthCare of KY, Inc dba Vangard Labs||050052943||RELABEL(0615-7773), REPACK(0615-7773)|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.